Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
The GSLV-F18 rocket carrying the NVS-03 navigation satellite was successfully launched by the ISRO (Indian…
The IIFA (International Indian Film Academy) Awards of 2026 were held as the 26th edition…
India will observe the 151st Birth Anniversary of Sardar Vallabhbhai Patel on 31 October 2026.…
The chinar trees of Kashmir are famous for the way they change the scenery of…
The Ministry of Labour and Employment has issued the Constitution of the National Social Security…
India Biennale 2026, the second version of the India Art, Architecture and Design Biennale, is…